(VIANEWS) – The NYSE ended the session with West Pharmaceutical rising 14.45% to $319.51 on Thursday, after five successive sessions in a row of gains. NYSE fell 0.75% to $15,895.20, after two consecutive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
West Pharmaceutical’s last close was $279.18, 34.16% under its 52-week high of $424.00.
About West Pharmaceutical
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Earnings Per Share
As for profitability, West Pharmaceutical has a trailing twelve months EPS of $5.57.
PE Ratio
West Pharmaceutical has a trailing twelve months price to earnings ratio of 57.38. Meaning, the purchaser of the share is investing $57.38 for every dollar of annual earnings.
Sales Growth
West Pharmaceutical’s sales growth is 1.1% for the current quarter and 3.4% for the next.
Yearly Top and Bottom Value
West Pharmaceutical’s stock is valued at $319.51 at 17:12 EST, way below its 52-week high of $424.00 and way higher than its 52-week low of $206.19.
Moving Average
West Pharmaceutical’s value is way higher than its 50-day moving average of $237.66 and way higher than its 200-day moving average of $284.87.
Volume
Today’s last reported volume for West Pharmaceutical is 1437700 which is 121.33% above its average volume of 649568.
More news about West Pharmaceutical (WST).
